Inosine, one of the upstream regulators of NLRP6-deficient CD103+ Bregs, can also be produced by the microbiota and is important in inhibition of severe autoimmunity (50), and improving the efficacy of checkpoint inhibitor therapy in colorectal cancer (51). Here, NLRP6 is linked to Autoimmunity.